All stock lists
MERCK Kommanditgesellschaft auf Aktien (Deutsche Börse:MRK.DE)
DE · Delayed Price · Currency is EUR
Also listed: MER.SW, MKGAFHealthcare · Drug Manufacturers - Specialty & Generic
143.60+0.30 (+0.21%)
Insider Score
––Not scored
MRK.DE Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From MRK.DE’s reported statements · Q2 2026 (trailing 12 months)
Profitability16 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $21.14B
- Net income
- $2.37B
- Net margin
- 11.2%
Leverage12 / 20
A manageable debt load.
- Total debt
- $12.30B
- Cash
- $1.96B
- Net debt / EBITDA
- 1.63x
Liquidity16 / 20
Comfortably covers what is due within a year.
- Current assets
- $13.77B
- Current liabilities
- $8.13B
- Current ratio
- 1.69
Cash generation19 / 20
The business funds itself from operations.
- Operating cash flow
- $4.23B
- Free cash flow
- $2.64B
- FCF margin
- 12.5%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 434.8M
- Share growth (1y)
- 0.0%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
MRK.DE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 5.43 B | 5.13 B | 5.25 B | 5.32 B | 5.25 B | 5.28 B |
| Revenue Growth (YoY) | 3.41 % | -2.77 % | -3.12 % | 0.99 % | -1.81 % | 3.13 % |
| Cost of Revenue | 2.27 B | 2.07 B | 2.29 B | 2.10 B | 2.23 B | 2.13 B |
| Gross Profit | 3.17 B | 3.06 B | 2.96 B | 3.21 B | 3.03 B | 3.15 B |
| SG&A Expense | 1.31 B | 1.42 B | 1.52 B | 1.33 B | 1.41 B | 1.42 B |
| R&D Expense | 684.00 M | 658.00 M | 664.00 M | 660.00 M | 539.00 M | 551.00 M |
| Operating Expenses | 2.00 B | 2.07 B | 2.18 B | 2.00 B | 1.95 B | 1.97 B |
| Operating Income | 1.17 B | 992.00 M | 781.00 M | 1.22 B | 1.08 B | 1.18 B |
| Pretax Income | 640.00 M | 869.00 M | 401.00 M | 1.12 B | 829.00 M | 956.00 M |
| Tax Provision | 146.00 M | 200.00 M | 77.00 M | 224.00 M | 174.00 M | 218.00 M |
| Net Income | 490.00 M | 660.00 M | 319.00 M | 902.00 M | 652.00 M | 735.00 M |
| EPS (Basic) | 1.13 | 1.52 | 0.73 | 2.07 | 1.50 | 1.69 |
| EPS (Diluted) | 1.13 | 1.52 | 0.73 | 2.07 | 1.50 | 1.69 |
| Shares Outstanding | 434.78 M | 434.78 M | 434.78 M | 435.75 M | 434.78 M | 434.91 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.